C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home Markets Loading…
SVVC Equity

SVVC

OTCMKTS · SVVC

$0.01
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 3/5
41/100 composite
Fundamentals40
Regulatory49
Market40
Editorial30
Composite · trailing 12 months

Firsthand Technology Value is currently rated Neutral, with a composite score of 40.8. The company’s position within its rating band is influenced by moderate strength in regulatory oversight and weaker contributions from market and editorial factors. The regulatory pillar is the strongest driver, underpinned by the firm’s operations in the US jurisdiction and a respectable record in enforcement facets, though recent filing activity remains dormant. Despite a broad neutrality in the overall assessment, the lack of direct fundamentals data suggests an information vacuum that neither supports nor undermines the case for significant rerating.

The company's fundamentals are ambiguously positioned due to insufficient data, preventing a substantive analysis of revenue growth or margin projections. Market indicators are similarly obscured, lacking available quotations that might otherwise inform pricing momentum or sentiment shifts. Regulatory components present a mixed portrait, with enforcement stability lending some assurance, even as the absence of recent regulatory events keeps the cadence and potential critical updates low. The editorial pillar contributes limitedly, as both newsroom and brief hits are nonexistent, reflecting a deficiency in public news coverage.

Looking ahead, the most critical forward-looking catalyst remains regulatory scrutiny and filing cadence. Consistent regulatory engagement will likely determine the future trajectory of Firsthand Technology Value's market reception. Monitoring any developments in US jurisdictional posture or enforcement landscapes could illuminate paths for enhanced fundamentals transparency and market visibility that may transition the company out of its current neutral stance into a more distinctly rated position.

Scored: 2026-08-24Valid through: 2026-10-08Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
Corporate DetailsCompany profile
Headquarters
150 ALMADEN BLVD., SUITE 1250, SAN JOSE, CA, 95113
Phone
408-886-7096
SEC CIK
1495584
Website
Company website
Filings & DisclosuresPrimary sources
Annual report
Latest 10-K
Proxy statement
Latest DEF 14A
Filing portal
SEC EDGAR
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for SVVC (SVVC)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for SVVC (SVVC), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Risk Elevated. Headwinds: deep drawdown. (0 bullish signals, 2 bearish signals.)

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for SVVC are maintained by Cannabis Investor News and refreshed throughout the trading day.